Countdown!

A large number of medicines have entered the countdown to the withdrawal of medical insurance, and the national medical insurance catalog has entered the final stage
.

A large number of medicines have entered the countdown to the withdrawal of medical insurance, and the national medical insurance catalog has entered the final stage
.

Local medical insurance supplements are intensively transferred

Local medical insurance supplements are intensively transferred

Xinjiang (305)

Xinjiang (305)

Recently, the Xinjiang Medical Insurance Bureau issued the “Notice Regarding the Relocation of the Xinjiang Uygur Autonomous Region and the Xinjiang Production and Construction Corps’ Basic Medical Insurance, Work-Injury Insurance and Maternity Insurance Drug Lists to the Scope of Payments”.
Of the 453 drugs supplemented by local governments in the Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition), 358 drugs are still in the scope of payment
.

Starting from January 1, 2022, all the 305 varieties of non-ethnic medicines in the "Xinjiang Uygur Autonomous Region and Xinjiang Production and Construction Corps Drug Catalog for Basic Medical Insurance, Work Injury Insurance and Maternity Insurance" self-supplemented medicines will be transferred out of the scope of medical insurance payment
.

Anhui (149)

Anhui (149)

Earlier, on August 30, the Anhui Provincial Medical Insurance Bureau issued a notice confirming that the original provincial-level supplementary class B drug digestion work confirmed that the original provincial-level supplementary class B drugs in Anhui Province totaled 411, most of which have been digested in batches, and the last 149 Drugs will be transferred out of the Anhui Province Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug List and Outpatient Chronic Disease Drug List before December 31, 2021
.

It is worth noting that among the Class B supplementary drugs in Anhui Province, there have also been cases in which they have been successfully upgraded to national medical insurance products and escaped the fate of being cleared.
There are a total of 10-brinzolamide timolol and gadolinium.
Butrol, desloratadine citrate, roxithromycin, ornithine aspartate, multivitamin for injection (12), Anerning granules, Chuanqiong Qingnao granules, Gongxueting granules, safflower Wishful pill
.

Sichuan (145)

Sichuan (145)

On the same day as the above notice, the Sichuan Medical Insurance Bureau also issued a notice on the adjustment of medical insurance category B drugs to the digestive area, stating that 145 drugs such as boron ointment will no longer be included in the Sichuan Basic Medical Insurance and Work Injury Insurance from January 1, 2022.
And the scope of maternity insurance payment
.

Guizhou (339)

Guizhou (339)

On August 3, the Guizhou Medical Insurance Bureau and the Guizhou Department of Human Resources and Social Security issued the "Notice Regarding the Transfer of Some Medicines from the "Guizhou Province Basic Medical Insurance Work Injury Insurance and Maternity Insurance Drug Catalog (2021)", stating:

Starting from January 1, 2022, 339 drugs including cediiodine will be transferred out of the "Drug List
.

" Before the above-mentioned drugs are transferred out, continue to pay in accordance with the relevant provisions of the "Drug List"

Zhejiang (118)

Zhejiang (118)

On August 3, the Zhejiang Medical Insurance Bureau and the Zhejiang Human Resources and Social Security Bureau issued the "Notice on Transferring Some Medicines from the Zhejiang Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Lists" to require:

From January 1, 2022, 118 drugs including amoxicillin and dicloxacillin will be transferred out of the Zhejiang Provincial Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog
.

Jiangsu (156)

Jiangsu (156)

On July 14, the Jiangsu Provincial Medical Insurance Bureau issued the “Notice of the Jiangsu Provincial Department of Human Resources and Social Security on the Publication of the Second Batch of Digestible Lists of Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drugs List of Provincial Supplementary Drugs”, which clarified that since January 2022 Starting from the 1st, the cost of all imported medicines will no longer be included in the payment scope of Jiangsu Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Fund
.

Chongqing

Chongqing

According to the arrangement of the Chongqing Medical Insurance Bureau, the digestion time schedule for the local medical insurance products in Chongqing is as follows:

Medical insurance reimbursement for digestive drugs in the first year will cease from January 1, 2021; medical insurance reimbursement for digestive drugs in the second year will cease from January 1, 2022; digestive drugs in the third year from July 1, 2022 Stop medical insurance reimbursement
.

Digest the medicine in the second year, and stop medical insurance reimbursement from January 1, 2022;

Next year's medical insurance catalog will be unified nationwide

Next year's medical insurance catalog will be unified nationwide

The key points of a 2021 medical insurance work circulating a few days ago are clear: We must clean up and digest the provincial supplementary drug catalog to ensure that the national drug catalog is basically unified by 2022
.

As for the specific time next year, the country will completely realize the basic unification of the medical insurance catalogue? According to the analysis, the basic focus is to complete the clean-up of local medical insurance supplements before June 2022
.

The basic focus will be on completing the clean-up of local medical insurance supplements by June 2022
.

According to the schedule of related parties, the timetable for the transfer of local supplements to the medical insurance is as follows: 1.
The key monitoring list drugs are first removed from the medical insurance catalog; 2.
The remaining local supplements will be cleared within three years in principle, and the proportions of the three-year cleared varieties are respectively It is 40%, 40%, 20%
.

According to Cyberlan's latest statistics, Xinjiang, Anhui, Sichuan, Guizhou, Zhejiang, Jiangsu, and Chongqing will have a large number of drugs intensively transferred out of local medical insurance before January 1 next year
.

In Xinjiang, Anhui, Sichuan, Guizhou, Zhejiang, Jiangsu, and Chongqing, a large number of drugs will be intensively transferred out of local medical insurance before January 1 next year
.

Entering the third year of local medical insurance clearance is 2022, the last 20% of local medical insurance supplementary drugs need to be cleared
.

According to the "Notice on Doing a Good Job in Basic Medical Insurance for Urban and Rural Residents in 2021" issued by the National Medical Insurance Administration, the Ministry of Finance, and the State Administration of Taxation, all provinces (autonomous regions and municipalities) must complete the second batch of 40% supplementary products before the end of June 2021 Digestion work
.

In other words, from July this year to the middle of next year, it is the final stage of the transfer of supplementary products for local medical insurance
.

According to incomplete statistics from Cyberlan, as of now, Gansu, Ningxia, Xinjiang, Guangxi, Zhejiang, Shaanxi, Yunnan, Hunan, Jilin, Tianjin, Hebei, Anhui, Tibet, Beijing, Chongqing, Jiangsu, Qinghai, Chongqing, Sichuan, Henan Waiting for more than 20 provinces to implement the local supplement catalog recall policy
.

Many large varieties are affected

Many large varieties are affected

With the full elimination of supplementary drugs for local medical insurance, many large varieties will inevitably have a wave of shock
.

According to data from Mi Nei.
com, 41 local supplementary varieties have been included in 15 or more provinces, of which 35 are chemical medicines, and 6 are Chinese patent medicines, containing more than one billion major varieties
.

The more local supplemented varieties are included in more provinces, the more likely they are to be affected when they face clearing and retreat
.

The more local supplemented varieties are included in more provinces, the more likely they are to be affected when they face clearing and retreat
.

Cerebroside carnosine injection, cefoperazone tazobactam injection, oxiracetam injection, Yanhuning injection, ganglioside injection, thymopentin injection, creatine phosphate injection, sodium potassium magnesium calcium glucose injection, cephalosporin In 2020, the sales of 13 varieties of Dizine injection, Rhodiola rosea injection, Cefmendole injection, etc.
will exceed 1 billion yuan in the terminal of China's public medical institutions
.

For these varieties, in addition to striving to enter the national medical insurance catalog, becoming the third terminal of self-financed drugs and medical e-commerce are all the countermeasures that have to be made
.

What needs to be noticed is that with the completion of the clean-up of local medical insurance supplements, the annual regular adjustment of the national medical insurance catalog has become a more important window of opportunity for pharmaceutical companies
.

However, it is worth noting that even in the National Medical Insurance Catalogue, the withdrawal and price reduction of drugs are also occurring
.

The work plan for the adjustment of the medical insurance catalog in the past two years has stipulated that the medicines that have been cancelled, the risks are greater than the benefits, and are included in the negative list by the relevant departments will be transferred out of the national medical insurance
.

At the same time, the re-negotiation of renewal drugs, the increase of medical insurance payment restrictions for some varieties, and the negotiated price cuts for some drugs in the catalog have created considerable market pressure on the drugs in the national medical insurance
.

Negotiations for renewed drugs, increased medical insurance payment restrictions for certain varieties, and negotiated price cuts for some drugs in the catalog have all put considerable market pressure on drugs in the national medical insurance
.

The introduction of the medical insurance catalog in 2021 is already in the brewing stage-this year's national drug catalog adjustment is divided into preparation (June-July), declaration (July-August), expert review (August-September), and negotiation (9-10) Month), announcement of results (October-November) in 5 stages

According to this schedule, the medical insurance negotiations will begin soon

According to the requirements of relevant documents, subsequent localities should strictly implement the "Drug List", and must not formulate the list by themselves or use flexible methods to add drugs in the list, nor can they adjust the limited payment scope of the drugs in the list by themselves

With the full end of the local medical insurance retirement, the sole importance of national medical insurance to pharmaceutical companies is self-evident

Attachment: Many provinces transferred out the list of medical insurance drugs on January 1, 2022

Attachment: Many provinces transferred out the list of medical insurance drugs on January 1, 2022

Xinjiang (305)

Xinjiang (305)

Anhui (149)

Anhui (149)

Sichuan (145)

Sichuan (145)

Guizhou (339)

Guizhou (339)

Zhejiang (118)

Zhejiang (118)

Jiangsu (156)

Jiangsu (156)

Chongqing

Chongqing